Consequently, there is an urgent need for innovative chemical structures and strategies to bolster the stability of bioactive peptides, while the production is convenient and cost-effective
Over-loss and muscle pooled SURMOUNT, BMI below 22 reached by about 7% (as early as week 12), toward about 15% by week 88 in the longest trial, clinical underweight under 0.4% (Almandoz 2026)
Greater Improvements in Comorbidities Bariatric surgery is more effective at resolving obesity-related conditions such as: Type 2 diabetes (often complete remission) Sleep apnea Hypertension Joint pain PCOS and fertility issues Who Should Consider Bariatric Surgery
Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity